Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:1563-1570
Published online before print March 12, 2007, doi: 10.1161/CIRCULATIONAHA.106.666818
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/12/1563    most recent
CIRCULATIONAHA.106.666818v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ammar, K. A.
Right arrow Articles by Rodeheffer, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ammar, K. A.
Right arrow Articles by Rodeheffer, R. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Congestive
Right arrow Primary prevention
Right arrow Echocardiography
Right arrow Epidemiology

(Circulation. 2007;115:1563-1570.)
© 2007 American Heart Association, Inc.


Heart Failure

Prevalence and Prognostic Significance of Heart Failure Stages

Application of the American College of Cardiology/American Heart Association Heart Failure Staging Criteria in the Community

Khawaja Afzal Ammar, MD; Steven J. Jacobsen, MD, PhD; Douglas W. Mahoney, MS; Jan A. Kors, PhD; Margaret M. Redfield, MD; John C. Burnett, Jr, MD; Richard J. Rodeheffer, MD

From the Division of Cardiovascular Diseases (K.A.A., M.M.R., J.C.B., R.J.R.) and Division of Epidemiology (S.J.J., D.W.M.), Mayo Clinic and Foundation, Rochester, Minn; and the Department of Medical Informatics (J.A.K.), Erasmus University Medical Center, Rotterdam, the Netherlands.

Correspondence to Khawaja Afzal Ammar, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail ammar.khawaja{at}mayo.edu

Received March 9, 2006; accepted December 18, 2006.

Background— Heart failure (HF) is a progressive disorder associated with frequent morbidity and mortality. An American Heart Association/American College of Cardiology staging classification of HF has been developed to emphasize early detection and prevention. The prevalence of HF stages and their association with mortality are unknown. We sought to estimate HF stage prevalence in the community and to measure the association of HF stages with mortality.

Methods and Results— A population-based, cross-sectional, random sample of 2029 Olmsted County, Minnesota, residents aged ≥45 years was identified. Participants were classified by medical record review, symptom questionnaire, physical examination, and echocardiogram as follows: stage 0, healthy; stage A, HF risk factors; stage B, asymptomatic cardiac structural or functional abnormalities; stage C, HF symptoms; and stage D, severe HF. In the cohort, 32% were stage 0, 22% stage A, 34% stage B, 12% stage C, and 0.2% stage D. Mean B-type natriuretic peptide concentrations (in pg/mL) increased by stages: stage 0=26, stage A=32, stage B=53, stage C=137, and stage D=353. Survival at 5 years was 99% in stage 0, 97% in stage A, 96% in stage B, 75% in stage C, and 20% in stage D.

Conclusions— The present study provides prevalence estimates and prognostic validation for HF staging in a community cohort. Of note, 56% of adults ≥45 years of age were classified as being in stage A (risk factors) or B (asymptomatic ventricular dysfunction). HF staging underscores the magnitude of the population at risk for progression to overt HF.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
NEJMHome page
M. Jessup
MADIT-CRT -- Breathtaking or Time to Catch Our Breath?
N. Engl. J. Med., October 1, 2009; 361(14): 1394 - 1396.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. J. Eisen and S. R. Hankins
Continuous flow rotary left ventricular assist device: mechanical circulatory support 2.0.
J. Am. Coll. Cardiol., July 21, 2009; 54(4): 322 - 324.
[Full Text] [PDF]


Home page
CirculationHome page
W. Lieb, V. Xanthakis, L. M. Sullivan, J. Aragam, M. J. Pencina, M. G. Larson, E. J. Benjamin, and R. S. Vasan
Longitudinal Tracking of Left Ventricular Mass Over the Adult Life Course: Clinical Correlates of Short- and Long-Term Change in the Framingham Offspring Study
Circulation, June 23, 2009; 119(24): 3085 - 3092.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Kalogeropoulos, V. Georgiopoulou, S. B. Kritchevsky, B. M. Psaty, N. L. Smith, A. B. Newman, N. Rodondi, S. Satterfield, D. C. Bauer, K. Bibbins-Domingo, et al.
Epidemiology of Incident Heart Failure in a Contemporary Elderly Cohort: The Health, Aging, and Body Composition Study
Arch Intern Med, April 13, 2009; 169(7): 708 - 715.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. L. Baughman and J. A. Jarcho
Bridge to Life -- Cardiac Mechanical Support
N. Engl. J. Med., August 30, 2007; 357(9): 846 - 849.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Prevalence and Prognosis of Heart Failure by ACC/AHA Stage
Journal Watch Cardiology, April 18, 2007; 2007(418): 3 - 3.
[Full Text]